Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP642178.RAX00HrvDHGdITaStmGgvRqT5FvECaMxdBBDl20SFMFfk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP642178.RAX00HrvDHGdITaStmGgvRqT5FvECaMxdBBDl20SFMFfk130_assertion type Assertion NP642178.RAX00HrvDHGdITaStmGgvRqT5FvECaMxdBBDl20SFMFfk130_head.
- NP642178.RAX00HrvDHGdITaStmGgvRqT5FvECaMxdBBDl20SFMFfk130_assertion description "[Given their remarkable activity, CD19-CAR T cells are likely to be quickly incorporated into the management of B-cell neoplasms; these cells have become the paradigm for similar strategies targeting other cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642178.RAX00HrvDHGdITaStmGgvRqT5FvECaMxdBBDl20SFMFfk130_provenance.
- NP642178.RAX00HrvDHGdITaStmGgvRqT5FvECaMxdBBDl20SFMFfk130_assertion evidence source_evidence_literature NP642178.RAX00HrvDHGdITaStmGgvRqT5FvECaMxdBBDl20SFMFfk130_provenance.
- NP642178.RAX00HrvDHGdITaStmGgvRqT5FvECaMxdBBDl20SFMFfk130_assertion SIO_000772 24667955 NP642178.RAX00HrvDHGdITaStmGgvRqT5FvECaMxdBBDl20SFMFfk130_provenance.
- NP642178.RAX00HrvDHGdITaStmGgvRqT5FvECaMxdBBDl20SFMFfk130_assertion wasDerivedFrom befree-20150227 NP642178.RAX00HrvDHGdITaStmGgvRqT5FvECaMxdBBDl20SFMFfk130_provenance.
- NP642178.RAX00HrvDHGdITaStmGgvRqT5FvECaMxdBBDl20SFMFfk130_assertion wasGeneratedBy ECO_0000203 NP642178.RAX00HrvDHGdITaStmGgvRqT5FvECaMxdBBDl20SFMFfk130_provenance.